Infinant Health
Biotechnology Research • 
Davis, California, United States • 11-20 Employees
Company overview
| Headquarters | 2121 2nd St, Davis, California 95618, US |
| Phone number | +18444638486 |
| Websites | |
| NAICS | 541714 |
| Keywords | Drug Discovery, Metabolomics, Pharmaceutical Development, Metagenomics, Cognitive Development, Infant Health, Infant Gut Microbiome, Human Milk, Inflammation Control, Software As A Medical Device (Samd), Immune Development, Machine Learning As A Medical Device (Mlamd), Term/Preterm Infant Nutrition |
| Founded | 2012 |
| Employees | 11-20 |
| Socials |
Key Contacts at Infinant Health
Mandy Kennedy
Chief Marketing Officer
Mike Johnson
Chief Executive Officer
Rozana Zemlyansky
Sales Director
Samara Freeman
Founder
Carrie Mcguckin
Director Of National Sales & Clinical Education
Infinant Health Email Formats
Infinant Health uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@infinanthealth.com), used 69.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@infinanthealth.com | 92.3% |
{first name}{last name} | johndoe@evolvebiosystems.com | 7.7% |
About Infinant Health
Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to unintended consequences of modern medicine such as feeding and birthing practices. Now, there is a way to change that. What we found is that EVC001, our specific strain of B. infantis, is essential in developing a healthy microbiome and supporting healthy immune system function. We took that learning and developed INF108, a next-generation strain developed to prevent necrotizing enterocolitis (NEC) in pre-term infants. We believe the greatest chance to impact future health begins early, right after birth—a once in a lifetime opportunity where rapid development and radical changes occur. By unlocking human nutrition's full potential through introducing beneficial bacteria during early infancy, we can help build a foundation for better health. Investors in Infinant Health include Cargill and Bill & Melinda Gates Foundation, among others.
Infinant Health revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | $55,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Infinant Health has 6 employees across 6 departments.
Departments
Number of employees
Infinant Health Tech Stack
Discover the technologies and tools that power Infinant Health's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
CMS
CDN
JavaScript libraries
Analytics
Webmail
Miscellaneous
Security
Analytics
Video players
United Kingdom
Saudi Arabia
Spain
Canada
AustraliaFrequently asked questions
4.8
40,000 users
